Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats
Crossref DOI link: https://doi.org/10.1007/s11684-019-0689-5
Published Online: 2019-06-11
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Ruoxi
Chen, Jing
Liu, Diangang
Wang, Yu
Text and Data Mining valid from 2019-06-01
Version of Record valid from 2019-06-01
Article History
Received: 8 April 2018
Accepted: 27 December 2018
First Online: 11 June 2019